Clinical Trial

Phase IIa Study of Pharmacokinetics, Safety and Efficacy of QY201 Tablets in Adolescent Subjects With Moderate to Severe Atopic Dermatitis

Name: Phase IIa Study of Pharmacokinetics, Safety and Efficacy of QY201 Tablets in Adolescent Subjects With Moderate to Severe Atopic Dermatitis — clinical trial record (NCT07712536)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 2

View on ClinicalTrials.gov →

Summary

To evaluate the population pharmacokinetic characteristics of QY201 Tablets in adolescent participants with moderate to severe atopic dermatitis (AD).

Trial Details

NCT Number	NCT07712536
Lead Sponsor	E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.
Conditions	Adolescent Participants With Moderate to Severe Atopic Dermatitis (AD)
Enrollment	24 participants
Start Date	2025-06-04
Primary Completion	2025-12-19 (estimated)
Study Completion	2025-12-19 (estimated)
Updated on ClinicalTrials.gov	2026-07-17